216 related articles for article (PubMed ID: 27872089)
1. Transcriptional Induction of Periostin by a Sulfatase 2-TGFβ1-SMAD Signaling Axis Mediates Tumor Angiogenesis in Hepatocellular Carcinoma.
Chen G; Nakamura I; Dhanasekaran R; Iguchi E; Tolosa EJ; Romecin PA; Vera RE; Almada LL; Miamen AG; Chaiteerakij R; Zhou M; Asiedu MK; Moser CD; Han S; Hu C; Banini BA; Oseini AM; Chen Y; Fang Y; Yang D; Shaleh HM; Wang S; Wu D; Song T; Lee JS; Thorgeirsson SS; Chevet E; Shah VH; Fernandez-Zapico ME; Roberts LR
Cancer Res; 2017 Feb; 77(3):632-645. PubMed ID: 27872089
[TBL] [Abstract][Full Text] [Related]
2. A positive feedback loop between Periostin and TGFβ1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2α activation.
Chen G; Wang Y; Zhao X; Xie XZ; Zhao JG; Deng T; Chen ZY; Chen HB; Tong YF; Yang Z; Ding XW; Guo PY; Yu HT; Wu LJ; Zhang SN; Zhu QD; Li JJ; Shan YF; Yu FX; Yu ZP; Xia JL
J Exp Clin Cancer Res; 2021 Jun; 40(1):218. PubMed ID: 34193219
[TBL] [Abstract][Full Text] [Related]
3. The human sulfatase 2 inhibitor 2,4-disulfonylphenyl-tert-butylnitrone (OKN-007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1/SMAD2 and Hedgehog/GLI1 signaling.
Zheng X; Gai X; Han S; Moser CD; Hu C; Shire AM; Floyd RA; Roberts LR
Genes Chromosomes Cancer; 2013 Mar; 52(3):225-36. PubMed ID: 23109092
[TBL] [Abstract][Full Text] [Related]
4. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
[TBL] [Abstract][Full Text] [Related]
5. High-level expression of periostin is closely related to metastatic potential and poor prognosis of hepatocellular carcinoma.
Lv Y; Wang W; Jia WD; Sun QK; Li JS; Ma JL; Liu WB; Zhou HC; Ge YS; Yu JH; Xia HH; Xu GL
Med Oncol; 2013 Mar; 30(1):385. PubMed ID: 23275141
[TBL] [Abstract][Full Text] [Related]
6. AGK enhances angiogenesis and inhibits apoptosis via activation of the NF-κB signaling pathway in hepatocellular carcinoma.
Cui Y; Lin C; Wu Z; Liu A; Zhang X; Zhu J; Wu G; Wu J; Li M; Li J; Song L
Oncotarget; 2014 Dec; 5(23):12057-69. PubMed ID: 25474138
[TBL] [Abstract][Full Text] [Related]
7. The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation.
Lai JP; Oseini AM; Moser CD; Yu C; Elsawa SF; Hu C; Nakamura I; Han T; Aderca I; Isomoto H; Garrity-Park MM; Shire AM; Li J; Sanderson SO; Adjei AA; Fernandez-Zapico ME; Roberts LR
Hepatology; 2010 Nov; 52(5):1680-9. PubMed ID: 20725905
[TBL] [Abstract][Full Text] [Related]
8. Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma.
Lai JP; Sandhu DS; Yu C; Han T; Moser CD; Jackson KK; Guerrero RB; Aderca I; Isomoto H; Garrity-Park MM; Zou H; Shire AM; Nagorney DM; Sanderson SO; Adjei AA; Lee JS; Thorgeirsson SS; Roberts LR
Hepatology; 2008 Apr; 47(4):1211-22. PubMed ID: 18318435
[TBL] [Abstract][Full Text] [Related]
9. EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis.
Gu F; Yuan S; Liu L; Zhu P; Yang Y; Pan Z; Zhou W
J Cell Mol Med; 2019 Jun; 23(6):4208-4216. PubMed ID: 30957411
[TBL] [Abstract][Full Text] [Related]
10. Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/β-catenin-induced FGF18 expression in hepatocellular carcinoma.
Guo P; Wang Y; Dai C; Tao C; Wu F; Xie X; Yu H; Zhu Q; Li J; Ye L; Yu F; Shan Y; Yu Z; Dhanasekaran R; Zheng R; Chen G
Oncogene; 2018 Mar; 37(9):1220-1236. PubMed ID: 29242604
[TBL] [Abstract][Full Text] [Related]
11. Sulfatase-2 promotes the growth and metastasis of colorectal cancer by activating Akt and Erk1/2 pathways.
Tao Y; Han T; Zhang T; Sun C
Biomed Pharmacother; 2017 May; 89():1370-1377. PubMed ID: 28320104
[TBL] [Abstract][Full Text] [Related]
12. LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway.
Ji J; Tang J; Deng L; Xie Y; Jiang R; Li G; Sun B
Oncotarget; 2015 Dec; 6(40):42813-24. PubMed ID: 26540343
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation.
Mazzocca A; Fransvea E; Lavezzari G; Antonaci S; Giannelli G
Hepatology; 2009 Oct; 50(4):1140-51. PubMed ID: 19711426
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
[TBL] [Abstract][Full Text] [Related]
15. EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway.
Wang Y; Yu H; Shan Y; Tao C; Wu F; Yu Z; Guo P; Huang J; Li J; Zhu Q; Yu F; Song Q; Shi H; Zhou M; Chen G
J Exp Clin Cancer Res; 2016 Apr; 35():65. PubMed ID: 27066828
[TBL] [Abstract][Full Text] [Related]
16. The extracellular sulfatase SULF2 promotes liver tumorigenesis by stimulating assembly of a promoter-looping GLI1-STAT3 transcriptional complex.
Carr RM; Romecin Duran PA; Tolosa EJ; Ma C; Oseini AM; Moser CD; Banini BA; Huang J; Asumda F; Dhanasekaran R; Graham RP; Toruner MD; Safgren SL; Almada LL; Wang S; Patnaik MM; Roberts LR; Fernandez-Zapico ME
J Biol Chem; 2020 Feb; 295(9):2698-2712. PubMed ID: 31988246
[TBL] [Abstract][Full Text] [Related]
17. [Effects of periostin on hepatocellular carcinoma cells invasion, metastasis and prognosis].
Wen Q; Shang J; Mise SRL; Bai L
Zhonghua Gan Zang Bing Za Zhi; 2019 Oct; 27(10):766-771. PubMed ID: 31734990
[No Abstract] [Full Text] [Related]
18. Cbx4 governs HIF-1α to potentiate angiogenesis of hepatocellular carcinoma by its SUMO E3 ligase activity.
Li J; Xu Y; Long XD; Wang W; Jiao HK; Mei Z; Yin QQ; Ma LN; Zhou AW; Wang LS; Yao M; Xia Q; Chen GQ
Cancer Cell; 2014 Jan; 25(1):118-31. PubMed ID: 24434214
[TBL] [Abstract][Full Text] [Related]
19. CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
Zong G; Xu Z; Zhang S; Shen Y; Qiu H; Zhu G; He S; Tao T; Chen X
Dig Dis Sci; 2016 Aug; 61(8):2303-2314. PubMed ID: 27074923
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
